Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Urology, University of Minnesota, Minneapolis, Minnesota.
J Urol. 2021 Nov;206(5):1132-1138. doi: 10.1097/JU.0000000000001945. Epub 2021 Jun 29.
Radical cystectomy (RC) for the management of muscle-invasive bladder cancer remains a morbid procedure with high rates of perioperative complications. The role of preoperative immunonutritional supplementation (pre-INS) in improving post-RC outcomes is promising and needs further validation.
We performed a retrospective review of 204 patients who underwent RC for bladder cancer at a single institution, comparing patients who received oral L-arginine-based pre-INS, and those who did not. Preoperative features, postoperative complications, and readmission data were collected. Outcomes of interest included development of high-grade (Clavien-Dindo III-V) complications, readmission within 30 days, ileus, total parenteral nutrition (TPN) requirement, postoperative infection, and length of stay (LOS). Categorical and continuous outcomes were assessed using Fisher's exact test and Welch T-test, respectively. Multivariable logistic regression (MLoR) analysis was used to identify predictive factors for our outcomes.
Patients who received pre-INS had significantly lower odds of requiring postoperative TPN (17.3% vs 35.6%; Fisher p=0.015, OR=0.38) and developing postoperative infection (25% vs 45%; Fisher p=0.003; OR=0.41) but no significant difference in the rates of other outcomes. On MLoR, when adjusting for age, gender, body mass index, Charlson comorbidity index, undergoing neoadjuvant chemotherapy and operative features, pre-INS was a significant predictor of postoperative infection (Fisher p=0.02; OR=0.35) but not for high-grade complications, readmission, ileus, needing TPN or LOS.
Preoperative immunonutrition with an L-arginine-based supplement is associated with significant reduction in postoperative infection, one of the most common complications of RC.
根治性膀胱切除术(RC)治疗肌层浸润性膀胱癌仍然是一种术后并发症发生率较高的高风险手术。术前免疫营养补充(pre-INS)在改善 RC 术后结果方面的作用很有前景,但需要进一步验证。
我们对单中心 204 例膀胱癌患者行 RC 术后进行回顾性研究,比较了接受口服 L-精氨酸为基础的 pre-INS 治疗的患者和未接受 pre-INS 治疗的患者。收集了术前特征、术后并发症和再入院数据。感兴趣的结局包括发生高级别(Clavien-Dindo III-V 级)并发症、30 天内再入院、肠梗阻、全肠外营养(TPN)需求、术后感染和住院时间(LOS)。使用 Fisher 确切检验和 Welch T 检验评估分类和连续结局。使用多变量逻辑回归(MLoR)分析确定我们结局的预测因素。
接受 pre-INS 的患者术后需要 TPN 的可能性显著降低(17.3%比 35.6%;Fisher p=0.015,OR=0.38),术后感染的发生率也显著降低(25%比 45%;Fisher p=0.003;OR=0.41),但其他结局的发生率没有显著差异。在 MLoR 分析中,当调整年龄、性别、体重指数、Charlson 合并症指数、新辅助化疗和手术特征后,pre-INS 是术后感染的显著预测因素(Fisher p=0.02;OR=0.35),但不是高级别并发症、再入院、肠梗阻、需要 TPN 或 LOS 的预测因素。
术前给予 L-精氨酸为基础的免疫营养补充与术后感染显著减少相关,而术后感染是 RC 最常见的并发症之一。